Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor.

Radke L, Sandig G, Lubitz A, Schließer U, von Horsten HH, Blanchard V, Keil K, Sandig V, Giese C, Hummel M, Hinderlich S, Frohme M.

Bioengineering (Basel). 2017 Aug 15;4(3). pii: E70. doi: 10.3390/bioengineering4030070.

2.

Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycans.

Sandig G, von Horsten HH, Radke L, Blanchard V, Frohme M, Giese C, Sandig V, Hinderlich S.

Bioengineering (Basel). 2017 Apr 28;4(2). pii: E38. doi: 10.3390/bioengineering4020038.

3.

The determination of the radical power - an in vitro test for the evaluation of cosmetic products.

Herrling T, Seifert M, Sandig G, Jung K.

Int J Cosmet Sci. 2016 Jun;38(3):232-7. doi: 10.1111/ics.12279. Epub 2015 Nov 4.

PMID:
26383131
4.

Recombinant glycoproteins: The impact of cell lines and culture conditions on the generation of protein species.

Rosenlöcher J, Sandig G, Kannicht C, Blanchard V, Reinke SO, Hinderlich S.

J Proteomics. 2016 Feb 16;134:85-92. doi: 10.1016/j.jprot.2015.08.011. Epub 2015 Aug 24.

PMID:
26316330
5.

The human rhabdomyosarcoma cell line TE671--Towards an innovative production platform for glycosylated biopharmaceuticals.

Rosenlöcher J, Weilandt C, Sandig G, Reinke SO, Blanchard V, Hinderlich S.

Protein Expr Purif. 2015 Nov;115:83-94. doi: 10.1016/j.pep.2015.08.008. Epub 2015 Aug 10.

PMID:
26272370
6.

Adaptation of human CD4+ T cells to pathophysiological hypoxia: a transcriptome analysis.

Gaber T, Häupl T, Sandig G, Tykwinska K, Fangradt M, Tschirschmann M, Hahne M, Dziurla R, Erekul K, Lautenbach M, Kolar P, Burmester GR, Buttgereit F.

J Rheumatol. 2009 Dec;36(12):2655-69. doi: 10.3899/jrheum.090255. Epub 2009 Nov 2.

PMID:
19884271
7.

Oxidation-induced ferritin turnover in microglial cells: role of proteasome.

Mehlhase J, Sandig G, Pantopoulos K, Grune T.

Free Radic Biol Med. 2005 Jan 15;38(2):276-85.

PMID:
15607911
8.
9.

Antioxidants effectively prevent oxidation-induced protein damage in OLN 93 cells.

Ernst A, Stolzing A, Sandig G, Grune T.

Arch Biochem Biophys. 2004 Jan 1;421(1):54-60.

PMID:
14678784
10.

Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450.

Shou M, Norcross R, Sandig G, Lu P, Li Y, Lin Y, Mei Q, Rodrigues AD, Rushmore TH.

Drug Metab Dispos. 2003 Sep;31(9):1161-9.

PMID:
12920172
11.

Selective degradation of oxidatively modified protein substrates by the proteasome.

Grune T, Merker K, Sandig G, Davies KJ.

Biochem Biophys Res Commun. 2003 Jun 6;305(3):709-18. Review.

PMID:
12763051
12.

Standardized extracts of flavonoids increase the viability of PC12 cells treated with hydrogen peroxide: effects on oxidative injury.

Horáková L, Licht A, Sandig G, Jakstadt M, Duracková Z, Grune T.

Arch Toxicol. 2003 Jan;77(1):22-9. Epub 2002 Oct 16.

PMID:
12491037
13.

Alpha-lipoic acid prevents ethanol-induced protein oxidation in mouse hippocampal HT22 cells.

Pirlich M, Kiok K, Sandig G, Lochs H, Grune T.

Neurosci Lett. 2002 Aug 9;328(2):93-6.

PMID:
12133563
14.

Increased proteolysis after single-dose exposure with hepatotoxins in HepG2 cells.

Pirlich M, Müller C, Sandig G, Jakstadt M, Sitte N, Lochs H, Grune T.

Free Radic Biol Med. 2002 Jul 15;33(2):283-91.

PMID:
12106824
15.

Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.

Lin Y, Lu P, Tang C, Mei Q, Sandig G, Rodrigues AD, Rushmore TH, Shou M.

Drug Metab Dispos. 2001 Apr;29(4 Pt 1):368-74.

PMID:
11259318
16.

Regulation of endoplasmic reticulum biogenesis in response to cytochrome P450 overproduction.

Sandig G, Kärgel E, Menzel R, Vogel F, Zimmer T, Schunck WH.

Drug Metab Rev. 1999 May;31(2):393-410. Review. No abstract available.

PMID:
10335443

Supplemental Content

Loading ...
Support Center